A new database has been launched as part of the International Cancer Benchmarking Partnership (ICBP) Cancer Survival in High-Income Countries (SURVMARK-2) project, led by scientists from the International Agency for Research on Cancer (IARC) in collaboration with international partners. The tool assesses survival differences for eight cancer sites across seven countries with similar access to health care (Australia, Canada, Denmark, Ireland, New Zealand, Norway, and the United Kingdom).
This database complements the ICBP SURVMARK-2 project by expanding the available data on incidence, mortality, and survival trends with staging information. The database presents the distribution of cancer stage at diagnosis across countries, cancer sites, and age groups. It also reports estimated survival of patients across stage groups. The database contributes to the increasing knowledge on the role of screening and early detection, as well as the management of cancer patients, and how these can affect survival and help explain the observed survival differences across countries.
The launch of the online tool is complemented by the publication of multiple studies that explain survival by stage differences for ovarian cancer, colon cancer, and rectal cancer, as well as the potential role of treatment differences across ICBP countries.
Access the tool to explore the ICBP SURVMARK-2 database
Araghi M, Arnold M, Rutherford MJ, Guren MG, Cabasag CJ, Bardot A, et al.
Colon and rectal cancer survival in seven high-income countries 2010–2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project)
Gut, Published online 1 June 2020;
Cabasag CJ, Butler J, Arnold M, Rutherford M, Bardot A, Ferlay J, et al.
Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): a population-based study
Gynecol Oncol, Published online 1 April 2020;